|
Advertisement |
|
|
||
 |
|
|||||
|
|||||
|
 |
||||||
|
||||||
|
||||||
|
Journal of Clinical Oncology, Vol 25, No 9 (March 20), 2007: pp. 1067-1073 © 2007 American Society of Clinical Oncology. DOI: 10.1200/JCO.2006.08.5472 Decision Aids and Breast Cancer: Do They Influence Choice for Surgery and Knowledge of Treatment Options?
From the Section of General Surgery and Section of Plastic Surgery, Department of Surgery; and the Robert Wood Johnson Clinical Scholars Program and Division of General Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI Address reprint requests to Jennifer F. Waljee, MD, MPH, 6312 Medical Sciences Building I, 1150 West Medical Center Dr, Ann Arbor, MI 48109; e-mail: filip{at}med.umich.edu
Purpose To describe the effect of decision aids on the choice for surgery and knowledge of surgical therapy among women with early-stage breast cancer. Methods A systematic review was conducted between years 1966 to 2006 of all studies designed to assess the effect of decision aids on surgical therapy. MEDLINE, EMBASE, Cumulative Index to Nursing and Allied Health (CINAHL), the Cochrane Network, HAPI databases, and bibliographies were searched. Of the 123 studies screened, 11 studies met criteria. Meta-analyses were performed to assess the pooled relative risk for surgical choice and the pooled mean difference in patient knowledge. Results Results from randomized controlled trials indicated that women who used a decision aid were 25% more likely to choose breast-conserving surgery over mastectomy (risk ratio, 1.25; 95% CI, 1.11 to 1.40). Decision aids significantly increased patient knowledge by 24% (P = .024). The data also suggested that decision aids decreased decisional conflict and increased satisfaction with the decision-making process. Decision aids were well received by surgeons and patients, facilitated patients’ desire for shared decision making, and were feasible to implement into practice. Conclusion Decision aids are important adjuncts for counseling women with early-stage breast cancer. Their use increases the likelihood that women will choose breast-conserving surgery, and enhances patient knowledge of treatment options.
Breast cancer is the most commonly diagnosed malignancy in women, and nearly all will face surgery as a component of their treatment. For early-stage breast cancer, multiple randomized trials have demonstrated equivalent survival between breast-conserving surgery (BCS) and mastectomy for early-stage breast cancer. In 1991, the National Cancer Institute advocated BCS as the preferred surgical treatment for early breast cancer.1-4 However, wide variation in the receipt of BCS persists, raising concern that women with breast cancer may not adequately participate in their decision for surgery.5,6 Prior research has revealed that only 50% of women with early breast cancer participate in the decision for surgery to the extent that they desire.7 Although the mechanisms underlying this finding are not entirely known, patients may feel ill-equipped to participate due to lack of information, or are intimidated by the decision process when faced with a cancer diagnosis. Decision aids have been advocated to promote patient involvement in the decision-making process for treatment options by streamlining and standardizing communication between the patient and provider.8 These tools are designed to help patients make informed choices by detailing the outcomes of specific health care alternatives. The majority of patients use some type of informational material when making health care choices, such as educational audiotapes, videotapes, and text materials obtained from health care providers, and more 80% use health pamphlets or brochures.9-11 In general, health literacy is correlated with improved patient outcomes, and patients with inadequate knowledge of their disease states are more likely to be hospitalized and have poorer disease-management capabilities.12-15 Thus, decision aids have an important role in the treatment process for women with early-stage breast cancer. However, the extent to which decision aids influence the surgical choice and patient knowledge of treatment options is not known. Our purpose was to perform a systematic review and meta-analysis of the published literature regarding the use of surgical decision aids among women with early-stage breast cancer. Our specific study objectives were to comprehensively review the literature regarding decision aids for the surgical treatment of early breast cancer, and estimate summary effects of decision aids on the type of breast cancer surgery chosen and patient knowledge of breast cancer treatment.
Literature Search To identify potentially relevant studies, we searched the MEDLINE, EMBASE, CINAHL, the Cochrane Network, and HAPI databases from January 1966 through July 1, 2006. We exploded the following medical subject heading terms: patient decision making, computer assisted patient decision making; therapy, computer assisted decision support systems, decision aid, health education, patient education, patient satisfaction, patient participation, physician-patient relations, clinical trial, patient information, and medical information. We then combined these medical subject heading terms with the terms breast neoplasms, breast cancer, and surgery. We included articles published in any language, and manually reviewed the reference lists from potentially relevant papers in an effort to identify any additional studies that may have been missed with our electronic database search. The end date of the search was July 1, 2006. The search was conducted by one author (J.W.), and repeated independently by a research librarian. In addition, we conducted an extensive search for unpublished work in this area using the same search terms. We searched abstracts from the following organizations: American Society of Clinical Oncology, the Society of Surgical Oncology, the Society for Medical Decision Making, Center for the Advancement of Health, Center for Health and Well-Being, Institute for Health Care Improvement, American College of Physicians, National Coalition on Health Care, and the RAND Corporation. This search yielded one additional study that matched our search criteria.
Study Selection Criteria
Data Extraction
Statistical Analyses
For assessment of the impact of decision aids on patient knowledge, standardized mean differences (between decision aid and control groups) were pooled using inverse variance weighting for all randomized controlled trials.
Our search yielded 116 articles and seven unpublished abstracts, of which 11 met the study criteria (Table 1). Three studies were randomized controlled trials (RCTs), two of which were conducted in Canada and one of which was conducted in the United States.16-18 One study in the Netherlands yielded three publications and was a nonrandomized trial with rotating concurrent controls over multiple 6-month time periods at three hospitals.19-21 Another nonrandomized trial conducted in Canada used historical controls.27 The historical controls were a select group of patients (19% were excluded for various reasons) who underwent surgery for breast cancer during the 18-month period before the introduction of the decision aid. There were also four nonrandomized studies without control groups, two of which included newly diagnosed breast cancer patients and two of which used student proxies as cases or controls.22-25
An overview of the types of decision aids in each of the studies is listed in Table 2. Overall, the majority of the decision aids were conducted in an office setting, but few required direct physician involvement. Approximately half of the decision aids used photographs, and half of the decision aids were computer based. All of the decision aids included information regarding the risks and benefits of both mastectomy and BCS.
Final Treatment Decision The effect of decision aids on the receipt of surgery (BCS or mastectomy) varied by the type of study design. Figure 1 illustrates the differences in proportions of women who chose BCS by study and treatment group for the trials (both randomized and nonrandomized) with concurrent controls. Overall usage of BCS was high; it was the preferred method of surgery in all three studies. Results from the RCTs (Fig 2) showed that women who used a decision aid were 25% more likely to choose BCS than mastectomy compared with women who did not use a decision aid (random-effects pooled RR, 1.25; 95% CI, 1.11 to 1.40). The effect was consistent across RCTs (I2 = 0%; Cochran's Q test  2 = 0.21; P = .651). Results from the fixed-effects model were the same (RR, 1.25; 95% CI, 1.11 to 1.40).
For nonrandomized controlled trials, the random-effects pooled RR for the association between decision aids and type of surgery was 0.94 (95% CI, 0.72 to 1.23), and there was no difference in surgical choice by use of a decision aid. The study by Molenaar et al21 used concurrent controls and although the point estimate was above the null (RR = 1.09), the results were not significant. The study by Whelan et al27 in 1999 used a selected subset of former patients as historical controls and found that the use of a decision aid resulted in a greater likelihood of mastectomy. In multivariate analyses conducted by two studies, significant predictors of patient's surgical choice were the surgeon's recommendation and patient's concerns regarding breast loss and tumor recurrence, not receipt of a decision aid.16,21 Among the studies that did not use a control group, the majority of patients reported they would opt for BCS.22
Patient Knowledge Five studies reported a significant increase in knowledge after use of the decision aid.16,17,22,24,27 Only one study found no significant difference in knowledge by receipt of a decision aid.18 Areas in which patients gained the most knowledge included understanding postoperative survival, radiation therapy, and recurrence after BCS. In addition, patients with lower baseline knowledge scores had the most pronounced increase in knowledge in several of the studies. Three RCTs reported mean knowledge scores in both the decision aid and control groups (Fig 3). The pooled estimate for the difference in mean knowledge scores was 0.24 in both fixed- and random-effects models (95% CI, 0.03 to 0.45), indicating that there was a significant increase in average knowledge scores by 24% in patients who received a decision aid compared with controls. Cochran's Q test for heterogeneity was not significant (P = .571), with I2 = 0%.
Decisional Conflict and Satisfaction Several studies assessed the effect of decision aids on patient satisfaction and conflict with their decision for surgery, using the decisional conflict scale. This 16-item instrument is designed to determine how informed patients feel regarding their choices, the associated benefits and risks, the clarity of their values, support during the decision-making process, and level of uncertainty.26 Molenaar et al19 used an additional scale developed by the authors to assess patient satisfaction. Overall, decision aids reduced decisional conflict and increased patients’ satisfaction with their decisions.1618,19,24 Women who initially preferred a mastectomy or who were unsure of their preference experienced the most pronounced decline in decisional conflict after receiving the decision aid. In addition, patients who received a decision aid were more likely to perceive they were offered a clear choice between the two options by their surgeon, and were more likely to prefer the treatment they chose.16
Convenience and Ease of Use Two studies used qualitative methodology to assess the use of a decision aid for the decision for surgery.22,24 Patients responded that photographs were useful aspects in the decision aid, and few women found them inappropriate or frightening. Areas of uncertainty included the use of adjuvant chemotherapy, long-term radiation effects, breast reconstruction, staging tests, breast cancer recurrence, and the timing of the surgical decision. However, only 69% of patients reported they had gained all of the information necessary to participate in the therapy decision.
Surgeon Perspectives
Quality of Life
In this review, women with early-stage breast cancer who received counseling with a decision aid were 20% more likely to receive BCS compared with women who did not receive counseling with a decision aid. Decision aids significantly improved patient knowledge regarding treatment options, and increased patient satisfaction with the decision-making process. Finally, decision aids were well received by both surgeons and patients across all studies. In addition to surgery for breast cancer, decision aids have been studied for other types of health decisions. In a recent review by O'Connor et al, decision aids were most helpful for patients who were uncertain regarding their preferences for treatment.34,35 Consistent with our findings, decision aids increased patient knowledge of treatment options and provided patients with more realistic expectations of outcomes. Decision aids have also been studied among men diagnosed with prostate cancer. These patients reported improved discussion with physicians regarding treatment options and increased knowledge of possible adverse effects of treatment after use of a decision aid.36 Finally, decision aids have been evaluated across other aspects breast cancer treatment, including the decision for radiation therapy and adjuvant chemotherapy, and the decision for surgical therapy for women with genetic predispositions to breast cancer.37-39 In these settings, decision aids were acceptable to patients, effectively elicited treatment preferences, increased patient knowledge regarding treatment options, and facilitated shared decision making between the patient and provider. As a systematic review and meta-analysis, this study is limited by the variation in the types of decision aids used in the published reports. Although all the decision aids included information regarding the risks and benefits of both mastectomy and BCS, they varied in the type and format of delivery, and the amount of physician involvement required. Regardless of the variation in the types of decision aids, our results demonstrate a consistent effect of decision aids on the choice of surgical procedure and patient knowledge of treatment options. Our review is also subject to publishing bias, although we attempted to identify unpublished data by review of abstracts from multiple sources. Finally, a notable limitation is the paucity of studies conducted in women from the United States on this topic. Given that the decision-making process often has socioeconomic and cultural underpinnings, it is unknown whether these results are generalizable to all racial, ethnic, and socioeconomic groups of women in the United States. Despite these limitations, our study reveals that decision aids may increase patients’ ability to make informed choices for surgery and potentially can improve the quality of care for breast cancer patients. For example, decision aids can be integrated into the informed consent process to document patient knowledge of surgical treatment. These tools may reassure surgeons that their patients are adequately informed and can highlight areas of patient uncertainty regarding surgery. Decision aids also allow women to participate more effectively in the decision for surgery by increasing their knowledge of treatment options. Women who participate in the decision for surgery at the level they desire are more likely to report that are adequately informed, and are more satisfied with treatment outcomes and the decision process.7,40 Decision aids are already being incorporated into health care policy for breast cancer. For example, some states have proposed legislation requiring physicians to provide patients with decision aids during consultation. Such efforts can increase awareness of disparities in breast cancer treatment, and provide an opportunity to develop a standardized decision tool for patients with breast cancer. However, legislation alone is unlikely to change surgeon practices. For example, BCS rates increased transiently after the passage of state laws requiring physicians to disclose all surgical options for women with breast cancer. Within a year, however, BCS rates had returned to previous levels.41 Similarly, rates of breast reconstruction after mastectomy did not change after the 1999 Women's Health and Cancer Rights Act, which mandated the coverage of breast reconstruction after mastectomy for breast cancer by insurers.42 In addition to legislation, future research is needed to identify the optimal strategy to assimilate decision aids into standard practice. Additional study of decision aids will inform efforts to improve the quality of care for breast cancer patients. Little is known regarding the quality of information contained in decision aids for breast cancer, and the accuracy of these tools may be highly variable. A recent study of decision aids for prostate cancer treatment revealed more than 90% of informational tools do not describe all standard treatments, only 30% include the risks and benefits of each treatment, and most do not contain enough information to meet the requirements of informed consent.43 In addition, the inclusion and presentation of specific elements may influence patients’ preference for treatments. For example, patients may have difficulty understanding probabilistic outcomes such as survival and local recurrence.44 Women's perceptions of risk are highly variable, and often influenced by the display format of information.45-48 Identifying aspects of decision aids that are most salient to women facing a decision for surgery will improve the quality of these tools, and facilitate their implementation into routine practice. As treatment decisions increase in complexity due to the advent of new technologies and treatment options, such as neoadjuvant chemotherapy, the ability to inform and educate our patients properly becomes paramount. Decision aids will continue to be an important adjunct for counseling women with breast cancer, and can improve the quality of health care delivered to these patients.
The authors indicated no potential conflicts of interest.
Conception and design: Jennifer F. Waljee, Amy K. Alderman Financial support: Jennifer F. Waljee Administrative support: Jennifer F. Waljee, Mary A.M. Rogers, Amy K. Alderman Provision of study materials or patients: Jennifer F. Waljee, Amy K. Alderman Collection and assembly of data: Jennifer F. Waljee, Mary A.M. Rogers, Amy K. Alderman Data analysis and interpretation: Jennifer F. Waljee, Mary A.M. Rogers, Amy K. Alderman Manuscript writing: Jennifer F. Waljee, Mary A.M. Rogers, Amy K. Alderman Final approval of manuscript: Jennifer F. Waljee, Mary A.M. Rogers, Amy K. Alderman
Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.
1. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002 2. NIH Consensus Conference: Treatment of early-stage breast cancer. JAMA 265:391-395, 1991 3. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002 4. Fisher B, Jeong JH, Anderson S, et al: Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347:567-575, 2002 5. Nattinger AB, Gottlieb MS, Veum J, et al: Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326:1102-1107, 1992[Abstract] 6. Nattinger AB, Goodwin JS: Geographic and hospital variation in the management of older women with breast cancer. Cancer Control 1:334-338, 1994[Medline] 7. Keating NL, Guadagnoli E, Landrum MB, et al: Treatment decision making in early-stage breast cancer: Should surgeons match patients’ desired level of involvement? J Clin Oncol 20:1473-1479, 2002 8. O'Connor AM: A call to standardize measures for judging the efficacy of interventions to aid patients’ decision making. Med Decis Making 19:504-505, 1999 9. Fagerlin A, Lakhani I, Lantz PM, et al: An informed decision? Breast cancer patients and their knowledge about treatment. Patient Educ Couns 64:303-312, 2006[CrossRef][Medline] 10. James C, James N, Davies D, et al: Preferences for different sources of information about cancer. Patient Educ Couns 37:273-282, 1999[CrossRef][Medline] 11. Rees CE, Bath PA: Information-seeking behaviors of women with breast cancer. Oncol Nurs Forum 28:899-907, 2001[Medline] 12. Gazmararian JA, Williams MV, Peel J, et al: Health literacy and knowledge of chronic disease. Patient Educ Couns 51:267-275, 2003[CrossRef][Medline] 13. Baker DW, Gazmararian JA, Williams MV, et al: Functional health literacy and the risk of hospital admission among Medicare managed care enrollees. Am J Public Health 92:1278-1283, 2002 14. Weiss BD, Hart G, McGee DL, et al: Health status of illiterate adults: Relation between literacy and health status among persons with low literacy skills. J Am Board Fam Pract 5:257-264, 1992[Medline] 15. Baker DW, Parker RM, Williams MV, et al: The relationship of patient reading ability to self-reported health and use of health services. Am J Public Health 87:1027-1030, 1997 16. Whelan T, Levine M, Willan A, et al: Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: A randomized trial. JAMA 292:435-441, 2004 17. Street RL Jr, Voigt B, Geyer C Jr, et al: Increasing patient involvement in choosing treatment for early breast cancer. Cancer 76:2275-2285, 1995[CrossRef][Medline] 18. Goel V, Sawka CA, Thiel EC, et al: Randomized trial of a patient decision aid for choice of surgical treatment for breast cancer. Med Decis Making 21:1-6, 2001 19. Molenaar S, Sprangers MA, Rutgers EJ, et al: Decision support for patients with early-stage breast cancer: Effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life. J Clin Oncol 19:1676-1687, 2001 20. Molenaar S, Sprangers MA, Rutgers EJ, et al: Interactive cd-rom on the choice between breast-sparing treatment and mastectomy: Positive responses from patients and surgeons. Ned Tijdschr Geneeskd 145:1004-1008, 2001[Medline] 21. Molenaar S, Oort F, Sprangers M, et al: Predictors of patients’ choices for breast-conserving therapy or mastectomy: A prospective study. Br J Cancer 90:2123-2130, 2004[Medline] 22. Vodermaier A, Caspari C, Kohm J, et al: Shared decision-making in primary breast cancer. Z Arztl Fortbild Qualitatssich 98:127-133, 2004[Medline] 23. Chapman GB, Elstein AS, Hughes KK: Effects of patient education on decisions about breast cancer treatments: A preliminary report. Med Decis Making 15:231-239, 1995 24. Sawka CA, Goel V, Mahut CA, et al: Development of a patient decision aid for choice of surgical treatment for breast cancer. Health Expect 1:23-36, 1998[Medline] 25. Sepucha K, Collins E, O'Connor A, et al: Choosing a surgical approach in breast cancer: Patient's knowledge and values across the decision making process. Med Dec Making 2006 (abstr) 26. O'Connor AM: Validation of a decisional conflict scale. Med Decis Making 15:25-30, 1995[Medline] 27. Whelan T, Levine M, Gafni A, et al: Mastectomy or lumpectomy? Helping women make informed choices. J Clin Oncol 17:1727-1735, 1999 28. Ward S, Griffin J: Developing a test of knowledge of surgical options for breast cancer. Cancer Nurs 13:191-196, 1990[Medline] 29. Wilkin D, Hallam L, Doggett M: Measures of patient satisfaction, in Measures of Need and Outcome for Primary Care. Oxford, United Kingdom, 1992 30. Sprangers MA, Groenvold M, Arraras JI, et al: The European Organisation for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: First results from a three-country field study. J Clin Oncol 14:2756-2768, 1996 31. Stewart AL, Ware Jr JE, (eds): Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC, Duke University Press, 1992 32. Spielberger CD, Gorsuch RL, Lushene RE: STAI Manual for the State-Trait Anxiety Inventory. Palo Alto, CA, Consulting Psychologists Press, 1970 33. Devins GM, Orme CM, Costello CG: Measuring depressive symptoms in illness populations: Psychometric properties of the Center for Epidemiologic Studies Depression (CES-D) Scale. Psychol Health 2:139-156, 1988[CrossRef] 34. O'Connor AM, Fiset V, DeGrasse C, et al: Decision aids for patients considering options affecting cancer outcomes: Evidence of efficacy and policy implications. J Natl Cancer Inst Monogr 25:67-80, 1999 35. O'Connor AM, Stacey D, Entwistle V, et al: Decision aids for people facing health treatment or screening decisions. Oxford, United Kingdom, Cochrane Library, CD001431, 2, 2003 36. Holmes-Rovner M, Stableford S, Fagerlin A, et al: Evidence-based patient choice: A prostate cancer decision aid in plain language. BMC Med Inform Decis Mak 5:16, 2005[CrossRef][Medline] 37. Green MJ, Peterson SK, Baker MW, et al: Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: A randomized controlled trial. JAMA 292:442-452, 2004 38. Whelan TJ, Levine MN, Gafni A, et al: Breast irradiation postlumpectomy: Development and evaluation of a decision instrument. J Clin Oncol 13:847-853, 1995[Abstract] 39. Whelan TJ, Loprinzi C: Physician/patient decision aids for adjuvant therapy. J Clin Oncol 23:1627-1630, 2005 40. Lantz PM, Janz NK, Fagerlin A, et al: Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer. Health Serv Res 40:745-767, 2005[CrossRef][Medline] 41. Nattinger AB, Hoffman RG, Shapiro R, et al: The effect of legislative requirements on the use of breast-conserving surgery. N Engl J Med 335:1035-1040, 1996 42. Alderman AK, Wei Y, Birkmeyer JD: Use of breast reconstruction after mastectomy following the Women's Health and Cancer Rights Act. JAMA 295:387-388, 2006 43. Fagerlin A, Rovner D, Stableford S, et al: Patient education materials about the treatment of early-stage prostate cancer: A critical review. Ann Intern Med 140:721-728, 2004 44. Schapira MM, Nattinger AB, McHorney CA: Frequency or probability? A qualitative study of risk communication formats used in health care. Med Decis Making 21:459-467, 2001 45. Schapira MM, Nattinger AB, McAuliffe TL: The influence of graphic format on breast cancer risk communication. J Health Commun 11:569-582, 2006[CrossRef][Medline] 46. Fagerlin A, Zikmund-Fisher BJ, Ubel PA: How making a risk estimate can change the feel of that risk: Shifting attitudes toward breast cancer risk in a general public survey. Patient Educ Couns 57:294-299, 2005[CrossRef][Medline] 47. Fagerlin A, Wang C, Ubel PA: Reducing the influence of anecdotal reasoning on people's health care decisions: Is a picture worth a thousand statistics? Med Decis Making 25:398-405, 2005 48. Davids SL, Schapira MM, McAuliffe TL, et al: Predictors of pessimistic breast cancer risk perceptions in a primary care population. J Gen Intern Med 19:310-315, 2004[CrossRef][Medline] Submitted August 1, 2006; accepted December 12, 2006.
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||
|
|||||||||||
|
|
Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|
TOP
ABSTRACT
INTRODUCTION
mastectomy). Inverse variance was used for weights. Both fixed and random-effects (DerSimonian-Laird) models were used and Cochran's Q test of heterogeneity was performed. The index of inconsistency (I2) was also determined, which measures the proportion of inconsistency in individual studies that cannot be explained by random error. A sensitivity analysis was performed to evaluate potential differences in effect for randomized versus nonrandomized controlled trials. 
was set at .05 (two tailed). All analyses were conducted using STATA software (STATA Corp, College Station, TX). 
